Exploring the contribution of general self-efficacy to the use of self-care symptom management strategies by people living with HIV infection
Autor: | John Arudo, Cathy Bain, Linda Robinson, Mary Jane Hamilton, Dean Wantland, Inge B. Corless, Kenn M. Kirksey, Elizabeth Sefcik, Emily Huang, William L. Holzemer, Carmen J. Portillo, Shanaz Moezzi, Yvette P. Cuca, Patrice K. Nicholas, Sarie Human, Mary Maryland, Sue Willard, María E. Rosa |
---|---|
Rok vydání: | 2012 |
Předmět: |
Adult
Male Nausea Health Status Clinical Trials and Supportive Activities MEDLINE HIV Infections Severity of Illness Index law.invention Medication Adherence Quality of life (healthcare) Randomized controlled trial 7.1 Individual care needs law Clinical Research Virology Severity of illness Behavioral and Social Science medicine Humans Longitudinal Studies Depression (differential diagnoses) Randomized Controlled Trials as Topic Self-efficacy Physician-Patient Relations business.industry Public Health Environmental and Occupational Health Middle Aged Health Services Self Efficacy Self Care Infectious Diseases Mental Health Good Health and Well Being Behavioral and Psychosocial Research Quality of Life Public Health and Health Services Anxiety HIV/AIDS Female Management of diseases and conditions medicine.symptom business Clinical psychology |
Zdroj: | AIDS patient care and STDs, vol 26, iss 6 |
Popis: | General self-efficacy (GSE), the expectation that one is able to perform a behavior successfully, may differentiate those who are able to successfully utilize self-care symptom management strategies (SCSMS). This subanalysis (n=569) of an international 12 site longitudinal randomized controlled trial (RCT) (n=775), investigated GSE as an important factor determining symptom burden, SCSMS, engagement with the provider, and medication adherence over time, and identified differences in those with high and low GSE ratings concerning these variables. Parametric and nonparametric repeated-measures tests were employed to assess GSE and the perceived effectiveness of SCSMS for anxiety, depression, diarrhea, fatigue, nausea, and neuropathy. Symptom burden, engagement with the provider, and antiretroviral adherence were analyzed with regard to GSE. Our data indicated that there were differences in the perceived symptom burden over time of HIV infected individuals by GSE. Those individuals with higher GSE had fewer symptoms and these symptoms were perceived to be less intense than those experienced by the low GSE group. There were few meaningful differences in the SCSMS used by those with high versus low GSE other than the use of illicit substances in the low GSE group. The low GSE group was also significantly (p= |
Databáze: | OpenAIRE |
Externí odkaz: |